DE69836557D1 - Rekombinanten des infektiösen vogel-herpesvirus und rekombinante impfstoffe, die unter dessen verwendung hergestellt wurden - Google Patents

Rekombinanten des infektiösen vogel-herpesvirus und rekombinante impfstoffe, die unter dessen verwendung hergestellt wurden

Info

Publication number
DE69836557D1
DE69836557D1 DE69836557T DE69836557T DE69836557D1 DE 69836557 D1 DE69836557 D1 DE 69836557D1 DE 69836557 T DE69836557 T DE 69836557T DE 69836557 T DE69836557 T DE 69836557T DE 69836557 D1 DE69836557 D1 DE 69836557D1
Authority
DE
Germany
Prior art keywords
recombinant
herpesvirus
vaccines manufactured
bird
infectious bird
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69836557T
Other languages
English (en)
Other versions
DE69836557T2 (de
Inventor
Syuji Saito
Takashi Okuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeon Corp
Original Assignee
Zeon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeon Corp filed Critical Zeon Corp
Publication of DE69836557D1 publication Critical patent/DE69836557D1/de
Application granted granted Critical
Publication of DE69836557T2 publication Critical patent/DE69836557T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE69836557T 1997-10-03 1998-10-02 Rekombinanten des infektiösen vogel-herpesvirus und rekombinante impfstoffe, die unter dessen verwendung hergestellt wurden Expired - Lifetime DE69836557T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP27144597 1997-10-03
JP27144597 1997-10-03
PCT/JP1998/004468 WO1999018215A1 (fr) 1997-10-03 1998-10-02 Recombinants de virus herpetique infectieux aviaire et vaccins recombinants prepares avec ces derniers

Publications (2)

Publication Number Publication Date
DE69836557D1 true DE69836557D1 (de) 2007-01-11
DE69836557T2 DE69836557T2 (de) 2007-09-20

Family

ID=17500131

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69836557T Expired - Lifetime DE69836557T2 (de) 1997-10-03 1998-10-02 Rekombinanten des infektiösen vogel-herpesvirus und rekombinante impfstoffe, die unter dessen verwendung hergestellt wurden

Country Status (5)

Country Link
US (1) US6632664B1 (de)
EP (1) EP1026246B1 (de)
JP (1) JP3587065B2 (de)
DE (1) DE69836557T2 (de)
WO (1) WO1999018215A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030059799A1 (en) 2001-07-11 2003-03-27 Takashi Okuda Modified DNA molecule, recombinant containing the same, and uses thereof
US6764684B2 (en) 2001-09-28 2004-07-20 Zeon Corporation Avian herpesvirus-based recombinant infectious bursal disease vaccine
US6866852B2 (en) * 2002-01-31 2005-03-15 Zeon Corporation Recombinant herpesvirus of turkeys and use thereof
US6924135B2 (en) 2003-08-29 2005-08-02 Zeon Corporation DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof
WO2005093070A1 (ja) * 2004-03-29 2005-10-06 Zeon Corporation 組み換えヘルペスウイルス及びその利用
JP2005287422A (ja) * 2004-03-31 2005-10-20 Nippon Zeon Co Ltd 組み換えヘルペスウイルス及び多価ワクチン
JP2008228658A (ja) * 2007-03-20 2008-10-02 Nippon Zeon Co Ltd 新規なプロモーター、これを有する組み換え七面鳥ヘルペスウイルス、及びこれを利用した家禽用ワクチン
US20080241188A1 (en) 2007-03-30 2008-10-02 Zeon Corporation Turkey herpesvirus vectored recombinant containing avian influenza genes
US20090246226A1 (en) * 2008-03-28 2009-10-01 Zeon Corporation Avian vaccines possessing a positive marker gene
WO2010119112A1 (en) 2009-04-15 2010-10-21 Ceva Sante Animale Recombinant avian herpes virus vectors and vaccine for immunizing waterfowl species
BR112014008161A2 (pt) * 2011-10-21 2017-04-11 Intervet Int Bv vírus da doença de marek não patogênico recombinante, método para a preparação do mesmo, molécula do ácido nucleico, célula hospedeira, vacina para aves domésticas, método para a preparação de uma vacina, uso de um vírus da doença de marek não patogênico recombinante, e, método de vacinação de aves domésticas
ES2700243T3 (es) 2011-10-21 2019-02-14 Intervet Int Bv Construcciones del virus de la enfermedad de Marek recombinantes no patógenas que codifican antígenos del virus de la laringotraqueitis infecciosa y del virus de la enfermedad de Newcastle
PT2785373T (pt) * 2011-11-30 2020-01-27 Boehringer Ingelheim Animal Health Usa Inc Vectores de hvt recombinantes expressando antigénios de agentes patogénicos aviários e seus usos
EP2644702A1 (de) * 2012-03-30 2013-10-02 Ceva Sante Animale Multivalentes rekombinantes Vogelherpesvirus und Impfstoff zur Immunisierung von Vogelarten
EP2845904A1 (de) 2013-09-06 2015-03-11 Ceva Sante Animale Rekombinante Hühner-Herpesviren und deren Verwendungen
AR103245A1 (es) 2014-12-24 2017-04-26 Intervet Int Bv Vacuna vectorial basada en hvt (herpes virus de los pavos) frente a nd (enfermedad de newcastle) - ibd (enfermedad de gumboro) mejorada
EP4226936A3 (de) * 2015-03-05 2023-09-27 Northwestern University Nichtneuroinvasive viren und verwendungen davon
US20220040287A1 (en) 2018-12-21 2022-02-10 Ceva Sante Animale Recombinant avian herpes viruses containing multiple foreign genes
WO2021050701A1 (en) 2019-09-11 2021-03-18 Zoetis Services Llc Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
BR112022010825A2 (pt) 2019-12-20 2022-08-23 Intervet Int Bv Vacina de vetor hvt multivalente
CN116457461A (zh) 2020-10-15 2023-07-18 法国诗华动物保健公司 重组hvt及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965138A (en) * 1985-09-06 1999-10-12 Syntro Corporation Recombinant chimeric virus and uses thereof
EP0431668B1 (de) * 1989-12-04 1995-02-15 Akzo Nobel N.V. Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor
US5853733A (en) * 1993-02-26 1998-12-29 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
FR2719056B1 (fr) * 1994-04-20 1996-09-06 Rhone Merieux Herpesvirus transformés pour exprimer gD in vitro.
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
AU4489896A (en) 1994-12-30 1996-07-24 Rhone Merieux Avian recombinant live vaccine
FR2750866B1 (fr) 1996-06-27 1998-11-27 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
FR2757061B1 (fr) 1996-12-16 1999-03-26 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
FR2758986B1 (fr) 1997-01-31 1999-04-30 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire

Also Published As

Publication number Publication date
DE69836557T2 (de) 2007-09-20
EP1026246A1 (de) 2000-08-09
EP1026246B1 (de) 2006-11-29
US6632664B1 (en) 2003-10-14
EP1026246A4 (de) 2002-11-20
JPH11192093A (ja) 1999-07-21
JP3587065B2 (ja) 2004-11-10
WO1999018215A1 (fr) 1999-04-15

Similar Documents

Publication Publication Date Title
DE69836557D1 (de) Rekombinanten des infektiösen vogel-herpesvirus und rekombinante impfstoffe, die unter dessen verwendung hergestellt wurden
ATE275631T1 (de) Rekombinanter venezolanische-equine- pferdeenzephalitis-virusimpstoff
DE69511950D1 (de) Entkuppelbares selbstblockierendes Abseilgerät
PT1058558E (pt) Vacinas vivas recombinantes administradas com adjuvante
DE69529026D1 (de) Trehalose, ihre Herstellung und ihre Verwendung
BR9711853A (pt) Vacinas
NO20003303D0 (no) Vaksine
HUP0102441A3 (en) Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
ID20399A (id) Vaksin influensa
FI950514A0 (fi) Sientenvastaiset aineet, niiden valmistusmenetelmät ja välituotteet
DE69935606D1 (de) Adjuvanzsysteme und impfstoffe
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
DE59709806D1 (de) Cycloolefincopolymere, ihre verwendung und daraus hergestellte formkörper
AU4932601A (en) Recombinant parainfluenza virus expression systems and vaccines
NO995591D0 (no) Geler med forsinket, langvarig frigjörelse
DE60217002D1 (de) Kohlenstofffasern und Verbundwerkstoffe unter Verwendung derselben
DE69835433D1 (de) Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung
IL101780A0 (en) Recombinant avipox virus,the culture of cells infected with this virus and vaccines for poultry derived from this virus
FI971203A0 (fi) Tyyppiä 6A olevaa ihmisen papillomavirusta koodaava DNA
EP1204424A4 (de) Rekombinante rsv virus expressionssysteme und impfstoffe
EP1485488A4 (de) Rekombinante expressionssysteme für minusstrang-virus-rna und impfstoffe
DK1923071T3 (da) Equint herpesvirusvaccine
DE69735123D1 (de) Trehalose phosphorylase, deren Herstellung und Verwendung
DK1248650T3 (da) Forbedrede DNA-vacciner til bovint herpesvirus 1
DE1039889T1 (de) Immunoglobulinreiche milch, dessen herstellung und verwendung

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: SAITO, SYUJI, KAWASAKI, KANAGAWA, JP

Inventor name: OKUDA, TAKASHI, KAWASAKI, KANAGAWA, JP

8364 No opposition during term of opposition